190 related articles for article (PubMed ID: 18836892)
41. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
[TBL] [Abstract][Full Text] [Related]
42. Association of obesity with inflammation in occult chronic kidney disease.
Bavbek N; Isik B; Kargili A; Uz E; Uz B; Kanbay M; Turgut F; Karakurt F; Akcay A
J Nephrol; 2008; 21(5):761-7. PubMed ID: 18949732
[TBL] [Abstract][Full Text] [Related]
43. [Obesity as a risk factor of chronic kidney disease in patients undergoing primary angioplasty].
Bachórzewska-Gajewska H; Małyszko J; Małyszko J; Poniatowski B; Musiał W; Dobrzycki S; Kinalska I
Pol Arch Med Wewn; 2006 Oct; 116(4):916-23. PubMed ID: 18416292
[TBL] [Abstract][Full Text] [Related]
44. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.
Kramer H; Luke A; Bidani A; Cao G; Cooper R; McGee D
Am J Kidney Dis; 2005 Oct; 46(4):587-94. PubMed ID: 16183412
[TBL] [Abstract][Full Text] [Related]
45. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
[TBL] [Abstract][Full Text] [Related]
46. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).
Brown WW; Peters RM; Ohmit SE; Keane WF; Collins A; Chen SC; King K; Klag MJ; Molony DA; Flack JM
Am J Kidney Dis; 2003 Jul; 42(1):22-35. PubMed ID: 12830453
[TBL] [Abstract][Full Text] [Related]
47. Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women.
Sakurai M; Kobayashi J; Takeda Y; Nagasawa SY; Yamakawa J; Moriya J; Mabuchi H; Nakagawa H
J Epidemiol; 2016 Aug; 26(8):440-6. PubMed ID: 27087606
[TBL] [Abstract][Full Text] [Related]
48. Association between prehypertension and chronic kidney disease in the Japanese general population.
Yano Y; Fujimoto S; Sato Y; Konta T; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Yoshida H; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
Kidney Int; 2012 Feb; 81(3):293-9. PubMed ID: 21956189
[TBL] [Abstract][Full Text] [Related]
49. Waist-to-height ratio is the best index of obesity in association with chronic kidney disease.
Lin CH; Chou CY; Lin CC; Huang CC; Liu CS; Lai SW
Nutrition; 2007; 23(11-12):788-93. PubMed ID: 17884344
[TBL] [Abstract][Full Text] [Related]
50. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
[TBL] [Abstract][Full Text] [Related]
51. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study.
Ninomiya T; Kiyohara Y; Kubo M; Yonemoto K; Tanizaki Y; Doi Y; Hirakata H; Iida M
Am J Kidney Dis; 2006 Sep; 48(3):383-91. PubMed ID: 16931211
[TBL] [Abstract][Full Text] [Related]
52. Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.
Bansal N; Vittinghoff E; Plantinga L; Hsu CY
J Nephrol; 2012; 25(3):317-24. PubMed ID: 21725923
[TBL] [Abstract][Full Text] [Related]
53. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
54. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
[TBL] [Abstract][Full Text] [Related]
55. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo.
Sumaili EK; Cohen EP; Zinga CV; Krzesinski JM; Pakasa NM; Nseka NM
BMC Nephrol; 2009 Jul; 10():18. PubMed ID: 19622160
[TBL] [Abstract][Full Text] [Related]
56. Metabolic syndrome and chronic kidney disease.
Belarbia A; Nouira S; Sahtout W; Guedri Y; Achour A
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):931-40. PubMed ID: 26354564
[TBL] [Abstract][Full Text] [Related]
57. Changes in waist circumference and incidence of chronic kidney disease.
Barzin M; Hosseinpanah F; Serahati S; Salehpour M; Nassiri AA; Azizi F
Eur J Clin Invest; 2014 May; 44(5):470-6. PubMed ID: 24580088
[TBL] [Abstract][Full Text] [Related]
58. Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults.
Mottaghi A; Mirmiran P; Delshad H; Azizi F
J Am Coll Nutr; 2016; 35(7):587-596. PubMed ID: 26650689
[TBL] [Abstract][Full Text] [Related]
59. Effects of Body Weight Change on Development of Chronic Kidney Disease in Obese Metabolic Phenotypes.
Toda A; Hara S; Tsuji H; Arase Y
Nephron; 2022; 146(5):449-456. PubMed ID: 35184057
[TBL] [Abstract][Full Text] [Related]
60. Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease.
Obermayr RP; Temml C; Gutjahr G; Kainz A; Klauser-Braun R; Függer R; Oberbauer R
Nephrol Dial Transplant; 2009 Aug; 24(8):2421-8. PubMed ID: 19244226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
